MAM
KURA icon

Martingale Asset Management’s Kura Oncology KURA Stock Holding History

Martingale Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Buy
128,892
+11,198
+10% +$106K 0.03% 468
2026
Q1 		$957K Buy
+117,694
New +$1.01M 0.02% 506
2024
Q1 		– Sell
-21,222
Closed -$305K – 837
2023
Q4 		$305K Hold
21,222
– – 0.01% 698
2023
Q3 		$194K Sell
21,222
-44,932
-68% -$456K ﹤0.01% 751
2023
Q2 		$700K Buy
66,154
+23,435
+55% +$277K 0.01% 532
2023
Q1 		$522K Buy
+42,719
New +$533K 0.01% 604

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Martingale Asset Management's KURA Position: Q2 2026 in Review

Martingale Asset Management increased its Kura Oncology (KURA) stake by 9.5% in Q2 2026, buying an estimated $106K and bringing the position to 128,892 shares worth $1.41M. The position accounts for 0.03% of the portfolio, ranked #468.

Martingale Asset Management first reported a position in KURA in Q1 2023 and has held it in 6 quarters since. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Martingale Asset Management held 128,892 shares of Kura Oncology worth $1.41M as of Q2 2026.
  • Martingale Asset Management bought 11,198 Kura Oncology shares in Q2 2026, an estimated $106K.
  • Kura Oncology made up 0.03% of Martingale Asset Management's portfolio in Q2 2026, its #468 holding.
  • Martingale Asset Management first reported a position in Kura Oncology in Q1 2023 and has held it in 6 quarters since.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.